- Home
- SVT vs PYPD Comparison
SVT vs PYPD Comparison
Compare SVT & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVT
- PYPD
- Stock Information
- Founded
- SVT 1959
- PYPD 2008
- Country
- SVT United States
- PYPD Israel
- Employees
- SVT N/A
- PYPD N/A
- Industry
- SVT Industrial Machinery/Components
- PYPD Medical/Dental Instruments
- Sector
- SVT Consumer Discretionary
- PYPD Health Care
- Exchange
- SVT Nasdaq
- PYPD Nasdaq
- Market Cap
- SVT 27.1M
- PYPD 30.1M
- IPO Year
- SVT N/A
- PYPD 2020
- Fundamental
- Price
- SVT $10.60
- PYPD $2.75
- Analyst Decision
- SVT
- PYPD Strong Buy
- Analyst Count
- SVT 0
- PYPD 2
- Target Price
- SVT N/A
- PYPD $10.50
- AVG Volume (30 Days)
- SVT 921.0
- PYPD 13.1K
- Earning Date
- SVT 05-09-2025
- PYPD 05-07-2025
- Dividend Yield
- SVT N/A
- PYPD N/A
- EPS Growth
- SVT N/A
- PYPD N/A
- EPS
- SVT N/A
- PYPD N/A
- Revenue
- SVT $44,917,000.00
- PYPD N/A
- Revenue This Year
- SVT N/A
- PYPD N/A
- Revenue Next Year
- SVT N/A
- PYPD N/A
- P/E Ratio
- SVT N/A
- PYPD N/A
- Revenue Growth
- SVT 2.95
- PYPD N/A
- 52 Week Low
- SVT $10.16
- PYPD $2.37
- 52 Week High
- SVT $13.75
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- SVT 48.06
- PYPD 44.19
- Support Level
- SVT $10.33
- PYPD $2.66
- Resistance Level
- SVT $10.70
- PYPD $2.97
- Average True Range (ATR)
- SVT 0.23
- PYPD 0.13
- MACD
- SVT -0.03
- PYPD -0.02
- Stochastic Oscillator
- SVT 32.08
- PYPD 20.86
About SVT Servotronics Inc.
Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.